Atherotech Adds New Cardiometabolic Tests, Announces 2009 Growth
Atherotech Inc, developer of the VAP Cholesterol Test, has announced the addition of two new cardiometabolic tests as it continues to grow its cardiodiagnostic business.
Read MoreAtherotech Inc, developer of the VAP Cholesterol Test, has announced the addition of two new cardiometabolic tests as it continues to grow its cardiodiagnostic business.
Read MoreQuidel Corp, a leader in point-of-care (POC) rapid diagnostic tests, today announced recent initiatives to educate and inform the healthcare community regarding methodologies and procedures for use of the Companys QuickVue Influenza A+B POC Test in advance of the coming flu season.
Read MoreALDA Pharmaceuticals Corp announces that, in tests conducted at an independent laboratory in the US, T36 Antiseptic Hand Sanitizer has been shown to completely kill the new H1N1 Virus in 15 seconds or less.
Read MoreHHS Secretary Kathleen Sebelius announced that the United States Senate unanimously confirmed Dr. Francis Collins as the next Director of the National Institutes of Health.
Read MoreQuidel Corporation announced the addition of several executives to enhance its management team in the areas of science, technology and business development. Tim Stenzel, M.D., Ph.D. has been named Chief Scientific Officer. Working with Dr. Stenzel
Read More